Shanghai Junshi planning Hong Kong IPO

Shanghai Junshi Biosciences Co. Ltd. (Shanghai, China) proposed on Aug. 6 to list on Hong Kong Exchanges and Clearing Ltd. (HKEX) in an IPO.

On Aug. 1, Ascletis Pharma Inc. (HKSE:1672) became the first biotech to go public on the Hong Kong exchange since HKEX created a new prerevenue chapter, opening the door for biotechs to list (see "First Out the Gate")...